Cargando…

Azithromycin/favipiravir: Sinus bradycardia following interaction and off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008607/ http://dx.doi.org/10.1007/s40278-022-13249-9

Ejemplares similares

Dexamethasone/favipiravir/metoclopramide: Sinus bradycardia, deranged liver enzymes and off-label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Hypoglycaemia and off label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Methylprednisolone/umifenovir interaction: Sinus bradycardia and off label use: case report
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Ventricular tachycardia and off-label use: 2 case reports
Publicado: (2020)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Lengthening of the QT interval, bradycardia and atrioventricular block following an off-label use: case report
Publicado: (2020)

Dexamethasone/metoprolol-succinate/remdesivir: Sinus bradycardia following drug interaction and off label use: case report
Publicado: (2022)

SEVERE SINUS BRADYCARDIA INDUCED BY FAVIPIRAVIR
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Remdesivir: Sinus bradycardia and lack of efficacy following off-label use: 4 case reports
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Dexamethasone/remdesivir: Sinus bradycardia and off label use in COVID-19 and :case report
Publicado: (2021)

Favipiravir: Acute psychosis following off-label use: case report
Publicado: (2022)

Favipiravir: Liver injury following an off-label use: case report
Publicado: (2021)

Favipiravir: Acute pancreatitis following an off-label use: case report
Publicado: (2021)

Severe sinus bradycardia associated with favipiravir in a COVID‐19 patient
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Favipiravir: Lack of efficacy following off-label treatment: case report
Publicado: (2021)

Favipiravir: Hyperuricaemia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Favipiravir: Hyperuricaemia and acute gouty arthritis following off-label use: case report
Publicado: (2020)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

Azithromycin/methylprednisolone: Hyperglycaemia following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Methemoglobinemia following off-label use: case report
Publicado: (2020)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022)

Favipiravir/methylprednisolone: Off-label use and lack of efficacy: case report
Publicado: (2022)

Favipiravir/voriconazole: Hyperuricaemia, transaminitis and off-label use: case report
Publicado: (2021)

Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020)

Favipiravir/meropenem/vancomycin: Cholestatic liver injury following off-label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: DRESS syndrome following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Cardiac disorder followed by off-label use: case report
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir: Bradycardia and off-label-use: case report
Publicado: (2021)

Ceftriaxone/favipiravir/vancomycin: Lack of efficacy and off-label use: case report
Publicado: (2022)

Favipiravir: Bilateral foot ulcers, vasculitis and off-label use : case report
Publicado: (2021)

Colchicine/favipiravir/prednisolone: Lack of efficacy and off label use: case report
Publicado: (2021)

Favipiravir/levofloxacin/paracetamol: Severe thrombocytopenia and off-label use: case report
Publicado: (2021)

Favipiravir/tocilizumab: Increased lymphocyte count and transaminases following off-label use: 4 case reports
Publicado: (2021)

Azithromycin: Lack of efficacy and off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s3eingpu37fmds53q33kea5nsa